Home > Insider Trading > Avanir Pharmaceuticals Inc.

Avanir Pharmaceuticals Inc. (AVNR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Felix Baker's Baker Bros. Advisors Raises Positions In These Stocks

In several new filings with the Securities and Exchange Commission, Julian and Felix Bakers' healthcare-focused fund Baker Bros. Advisors reported raising its positions in Seattle Genetics, Inc.

Keep Reading →

November 12th, 2014 - Hedge Funds News

Neurocrine Biosciences, Inc. (NBIX), ChemoCentryx Inc (CCXI), Avanir Pharmaceuticals, Inc. (AVNR): Horrendous Health-Care Stocks Last Week

In a way, stocks go through seasons like the weather. Sometimes they spring forth, sometimes they're hot like summer, sometimes they're dormant and cold like winter. And sometimes they just fall.

Keep Reading →

September 16th, 2013 - News

Hedge Funds Are Betting On Momenta Pharmaceuticals, Inc. (MNTA)

Now, according to many market players, hedge funds are assumed to be bloated, outdated investment tools of a period lost to current times.

Keep Reading →

September 4th, 2013 - News

Hi-Tech Pharmacal Co. (HITK): Hedge Funds Aren't Crazy About It, Insider Sentiment Unchanged

To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.

Keep Reading →

September 3rd, 2013 - News

This Metric Says You Are Smart to Buy Sagent Pharmaceuticals Inc (SGNT)

If you were to ask many of your fellow readers, hedge funds are seen as useless, old investment tools of a forgotten age.

Keep Reading →

September 3rd, 2013 - News

MannKind Corporation (MNKD): What's the Latest: New Insulin Inhaler, Rating Reiterated by Zacks, Matthew J. Pfeffer & More

The long promise of insulin that diabetics can inhale appears to be moving closer to the market.

Keep Reading →

August 14th, 2013 - News

Hedge Funds Are Crazy About Ligand Pharmaceuticals Inc. (LGND)

At the moment, there are dozens of methods investors can use to monitor the equity markets. Some of the most useful are hedge fund and insider trading interest.

Keep Reading →

July 5th, 2013 - News

Is Supernus Pharmaceuticals Inc (SUPN) Going to Burn These Hedge Funds?

To most shareholders, hedge funds are perceived as slow, outdated investment vehicles of yesteryear.

Keep Reading →

June 27th, 2013 - News

Questcor Pharmaceuticals Inc (QCOR), Avanir Pharmaceuticals, Inc. (AVNR): 3 Humongous Healthcare Stocks This Past Week

Earlier this week, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) announced that it's buying rights to Synacthen from Novartis AG (ADR) (NYSE:NVS) for $135 million plus potential milestone payments.

Keep Reading →

June 17th, 2013 - News